Consistency of continual reassessment method under model misspecification
From MaRDI portal
Publication:3837320
DOI10.1093/biomet/83.2.395zbMath1059.62710OpenAlexW2075236916MaRDI QIDQ3837320
John O'Quigley, Larry Zaiqian Shen
Publication date: 1996
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biomet/83.2.395
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05)
Related Items
A new design of the continual reassessment method ⋮ Performance Measures in Dose‐Finding Experiments ⋮ Unnamed Item ⋮ Stochastic approximation and modern model-based designs for dose-finding clinical trials ⋮ A note on the robustness of the continual reassessment method ⋮ Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity ⋮ Adaptive clinical trial designs for phase I cancer studies ⋮ Dynamic calibration of pharmacokinetic parameters in dose-finding studies ⋮ On the consistency of the continual reassessment method with multiple toxicity constraints ⋮ Retrospective Analysis of Sequential Dose‐Finding Designs ⋮ Convergence properties of sequential Bayesian \(D\)-optimal designs ⋮ The treatment versus experimentation dilemma in dose finding studies ⋮ Unnamed Item ⋮ Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities ⋮ Theoretical study of the continual reassessment method ⋮ Dose-Finding Designs for HIV Studies ⋮ On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance ⋮ Curve-Free and Model-Based Continual Reassessment Method Designs ⋮ A Simple Technique to Evaluate Model Sensitivity in the Continual Reassessment Method ⋮ Continual Reassessment Method for Ordered Groups ⋮ A study of the probit model with latent variables in Phase I clinical trials
This page was built for publication: Consistency of continual reassessment method under model misspecification
